AdvaMed® Position Statement Regarding Transition to National Reimbursement Codes

AdvaMed® understands there has been some confusion surrounding our member plans to transition away from the acronyms NDC/NHRIC (National Drug Code/National Health Related Items Code) to National Reimbursement Code (NRC). This AdvaMed® position statement is intended to provide clarity about the transition, including rationale and implications.
Related Reading
News / Health Access / Regulatory Affairs
AdvaMed Spotlights Small Company Innovation Award Winners at The MedTech Conference 2026
October 22, 2026
BOSTON—AdvaMed, the Medtech Association, brought together innovators and industry leaders at The MedTech Conference 2026, held October 18-21 in Boston. The conference recognized companies developing technologies to address a diverse array of patient needs through awards offered in several competitions and programs.
News / Health Access / Regulatory Affairs
AdvaMed Convenes 13th Annual Symposium on Pediatric Device Innovation
October 22, 2026
BOSTON—AdvaMed, the Medtech Association, convened the 13th Annual Symposium on Pediatric Device Innovation on October 18 at The MedTech Conference 2026 in Boston. In collaboration with the five U.S. Food and Drug Administration-funded Pediatric Device Consortia and with support from the Mussallem CHD Alliance, the symposium brought together innovators, clinicians, regulators, investors, and patient advocates to address the evidence and access barriers that keep promising technologies from reaching children.
News / Medical Imaging / Regulatory Affairs / Standards
AdvaMed Names GE HealthCare’s John Jaeckle the 2026 Imaging Röntgen Award Recipient
October 16, 2026
WASHINGTON — AdvaMed, the Medtech Association, today announced that John Jaeckle, Chief Regulatory Affairs Strategist, at GE HealthCare, is the recipient of the 2026 AdvaMed Imaging Röntgen Award. The award recognizes Jaeckle’s more than 25 years of leadership in medical imaging regulation and standards development, including his work to advance computed tomography technology, performance and regulatory alignment in the United States and worldwide.
News / Health Access / Regulatory Affairs
AdvaMed Recommends Steps to Strengthen RAPID Pathway for Breakthrough Medical Technologies
October 8, 2026
WASHINGTON, D.C.—AdvaMed, the Medtech Association, today recommended refinements the Centers for Medicare & Medicaid Services (CMS) could make to help its proposed Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway deliver more timely access to breakthrough medtech for Medicare beneficiaries.
Event / Regulatory Affairs
AdvaMed Medical Device Submission Workshop Series
February 9, 2027 – February 28, 2027
Join industry leaders for the in-depth Medical Device Submissions Workshop series to receive real-world case studies, timely submissions tips, and best practices.
News / Health Access / Regulatory Affairs / Small Business
Emanate Receives FDA 510(k) Clearance for Perio PODS™, the First FDA-Cleared At-Home Periodontal Wound Dressing Indicated Following Non-Surgical Periodontal Procedures
September 18, 2026
NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) — Emanate Biomedical, Inc., a medical technology company creating a new category of clinician-directed at-home oral care, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for Perio PODS™, a periodontal wound dressing consisting of single-use, patient-matched dental trays preloaded with engineered hydrogel.
Event / Digital Health / Regulatory Affairs
Shifting Customer Engagement Models in Diagnostics: Winning in a Rapidly Evolving Market
September 29, 2026
2:00 PM – 3:00 PM
Join Deloitte in this discussion examining how rising consumer expectations, new technology entrants, and evolving provider roles are reshaping how diagnostics manufacturers engage their customers.
Event / Digital Health / Regulatory Affairs
Reimagining the Cost of Quality: The Agentic AI Opportunity for MedTech
September 30, 2026 10:00AM – 11:00AM ET
Join HCLTech in this discussion about practical use cases and strategies to scale AI-driven quality operations while maintaining compliance and enabling greater innovation.